☆ 4.6 Letter

Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: a European multi-national targeted chart review

CLINICAL KIDNEY JOURNAL (2020)

Get Full Text
Add to Collection

Journal

CLINICAL KIDNEY JOURNAL
Volume 13, Issue 4, Pages 714-719

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfz129

Keywords

-

Categories

Urology & Nephrology

Funding

  1. Vifor Pharma, Switzerland

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.